Related Experiment Video
Updated: Jun 23, 2025

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Intestinal Fatty Acid Binding Protein as a Predictor of Early Mesenteric Injury Preceding Clinical Presentation: A
Annet A M Duivenvoorden1, Flores M Metz2,3,4, Robin Wijenbergh5
1Department of Surgery, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Diagnosing non-occlusive mesenteric ischaemia (NOMI) is challenging. Intestinal fatty acid binding protein (I-FABP) may detect early mucosal damage, aiding timely diagnosis before clinical symptoms appear.
Area of Science:
- Vascular Surgery
- Gastroenterology
- Critical Care Medicine
Background:
- Non-occlusive mesenteric ischaemia (NOMI) presents diagnostic challenges due to non-specific symptoms and tests, leading to high mortality.
- Early detection of intestinal injury is crucial for improving patient outcomes in critical care settings.
Observation:
- A patient developed mesenteric ischaemia post-thoracic endovascular aneurysm repair (TEVAR) for type B aortic dissection (TBAD) complicated by cardiogenic shock.
- Elevated plasma intestinal fatty acid binding protein (I-FABP) levels were observed two days prior to the onset of clinical symptoms.
- The patient underwent emergency laparotomy and bowel resection due to peritonitis and perforation.
Findings:
- Plasma I-FABP levels increased significantly on post-operative days five and six.
- The elevated I-FABP levels preceded the clinical presentation of fever, peritonitis, and bowel perforation.
- Histopathological analysis confirmed mesenteric ischaemia.
Implications:
- Elevated I-FABP may serve as an early biomarker for mesenteric injury in high-risk patients.
- This case suggests I-FABP could aid in the early diagnosis of NOMI, potentially improving treatment strategies.
- Further research is warranted to validate I-FABP's utility in routine clinical practice for NOMI diagnosis.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

